These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30048137)

  • 1. An Indole-Chalcone Inhibits Multidrug-Resistant Cancer Cell Growth by Targeting Microtubules.
    Cong H; Zhao X; Castle BT; Pomeroy EJ; Zhou B; Lee J; Wang Y; Bian T; Miao Z; Zhang W; Sham YY; Odde DJ; Eckfeldt CE; Xing C; Zhuang C
    Mol Pharm; 2018 Sep; 15(9):3892-3900. PubMed ID: 30048137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure modification and biological evaluation of indole-chalcone derivatives as anti-tumor agents through dual targeting tubulin and TrxR.
    Yan J; Xu Y; Jin X; Zhang Q; Ouyang F; Han L; Zhan M; Li X; Liang B; Huang X
    Eur J Med Chem; 2022 Jan; 227():113897. PubMed ID: 34649064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
    Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
    Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and optimization of biphenyl derivatives as novel tubulin inhibitors targeting colchicine-binding site overcoming multidrug resistance.
    Cheng B; Zhu G; Meng L; Wu G; Chen Q; Ma S
    Eur J Med Chem; 2022 Jan; 228():113930. PubMed ID: 34794817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
    Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
    Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
    Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of pyridine-chalcone derivatives as novel microtubule-destabilizing agents.
    Xu F; Li W; Shuai W; Yang L; Bi Y; Ma C; Yao H; Xu S; Zhu Z; Xu J
    Eur J Med Chem; 2019 Jul; 173():1-14. PubMed ID: 30981112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel quinolone chalcones targeting colchicine-binding pocket kill multidrug-resistant cancer cells by inhibiting tubulin activity and MRP1 function.
    Lindamulage IK; Vu HY; Karthikeyan C; Knockleby J; Lee YF; Trivedi P; Lee H
    Sci Rep; 2017 Aug; 7(1):10298. PubMed ID: 28860494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel non-toxic and anti-angiogenic α-fluorinated chalcones as potent colchicine binding site inhibitors.
    Sun M; Yuan M; Kang Y; Qin J; Zhang Y; Duan Y; Wang L; Yao Y
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):339-354. PubMed ID: 34979843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biological evaluation, and molecular docking analysis of phenstatin based indole linked chalcones as anticancer agents and tubulin polymerization inhibitors.
    Kode J; Kovvuri J; Nagaraju B; Jadhav S; Barkume M; Sen S; Kasinathan NK; Chaudhari P; Mohanty BS; Gour J; Sigalapalli DK; Ganesh Kumar C; Pradhan T; Banerjee M; Kamal A
    Bioorg Chem; 2020 Dec; 105():104447. PubMed ID: 33207276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure optimization of an F-indole-chalcone (FC116) on 4-methoxyphenyl group and therapeutic potential against colorectal cancers with low cytotoxicity.
    Du B; Liu X; Luan X; Zhang W; Zhuang C
    Bioorg Chem; 2023 Jun; 135():106531. PubMed ID: 37043882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combretastatin-like chalcones as inhibitors of microtubule polymerization. Part 1: synthesis and biological evaluation of antivascular activity.
    Ducki S; Rennison D; Woo M; Kendall A; Chabert JF; McGown AT; Lawrence NJ
    Bioorg Med Chem; 2009 Nov; 17(22):7698-710. PubMed ID: 19837593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling based synthesis and evaluation of in vitro anticancer activity of indolyl chalcones.
    Gaur R; Yadav DK; Kumar S; Darokar MP; Khan F; Bhakuni RS
    Curr Top Med Chem; 2015; 15(11):1003-12. PubMed ID: 25860176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic Review on Cytotoxic and Anticancer Potential of N-Substituted Isatins as Novel Class of Compounds Useful in Multidrug-Resistant Cancer Therapy: In Silico and In Vitro Analysis.
    Gupta AK; Tulsyan S; Bharadwaj M; Mehrotra R
    Top Curr Chem (Cham); 2019 May; 377(3):15. PubMed ID: 31073777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, Anticancer Activity and Molecular Modeling Studies of Novel Chalcone Derivatives Containing Indole and Naphthalene Moieties as Tubulin Polymerization Inhibitors.
    Wang G; Peng Z; Li Y
    Chem Pharm Bull (Tokyo); 2019 Jul; 67(7):725-728. PubMed ID: 30982797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
    Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
    Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis and Bioactivity Evaluation of Novel Chalcone Derivatives Possessing Tryptophan Moiety with Dual Activities of Anti-Cancer and Partially Restoring the Proliferation of Normal Kidney Cells Pre-Treated with Cisplatin.
    He M; Yu M; Li C; Meng X; Su J; Zhu Y; Yao R
    Anticancer Agents Med Chem; 2022; 22(10):1945-1961. PubMed ID: 34674626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient synthesis of indole-chalcones based glycohybrids and their anticancer activity.
    Tyagi R; Yadav K; Khanna A; Mishra SK; Sagar R
    Bioorg Med Chem; 2024 Jul; 109():117778. PubMed ID: 38870714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroindole chalcone analogues targeting the colchicine binding site of tubulin for colorectal oncotherapy.
    Liu X; Jin J; Wu Y; Du B; Zhang L; Lu D; Liu Y; Chen X; Lin J; Chen H; Zhang W; Zhuang C; Luan X
    Eur J Med Chem; 2023 Sep; 257():115540. PubMed ID: 37301075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors.
    La Regina G; Bai R; Coluccia A; Naccarato V; Famiglini V; Nalli M; Masci D; Verrico A; Rovella P; Mazzoccoli C; Da Pozzo E; Cavallini C; Martini C; Vultaggio S; Dondio G; Varasi M; Mercurio C; Hamel E; Lavia P; Silvestri R
    Eur J Med Chem; 2018 May; 152():283-297. PubMed ID: 29730191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.